Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$47.8 - $66.66 $13.3 Million - $18.5 Million
-278,127 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$31.08 - $51.95 $1.09 Million - $1.82 Million
-35,000 Reduced 11.18%
278,127 $13.5 Million
Q1 2021

May 17, 2021

SELL
$35.64 - $85.46 $5.35 Million - $12.8 Million
-150,171 Reduced 32.41%
313,127 $12.2 Million
Q4 2020

Feb 16, 2021

BUY
$28.07 - $87.83 $13 Million - $40.7 Million
463,298 New
463,298 $28.7 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.54B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Trustees Of Columbia University In The City Of New York Portfolio

Follow Trustees Of Columbia University In The City Of New York and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Columbia University In The City Of New York, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Columbia University In The City Of New York with notifications on news.